Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Highlights

A cellular model to recreate the human muscle-nerve system


Researchers from I-Stem, IPSEN and LMN have conceived a cellular muscle-nerve model to test the therapeutic potential of botulinum toxins in vitro.
I-Stem, IPSEN & LMN recreate the human muscle-nerve system I-Stem, IPSEN & LMN recreate the human muscle-nerve system
Using human induced pluripotent stem cells, Cécile Martinat’s Motor Neuron Diseases team at I-Stem with colleagues from IPSEN Innovation and the Neurodegenerative Diseases Laboratory (Paris-Saclay University/CEA/CNRS) have created an in vitro cellular model of the human muscle-nerve system. When paired with optogenetics and calcium imaging technologies, this model of functional neuromuscular connections enables the study of the promising therapeutic potential of botulinum toxins in such settings as ophthalmology, neurology, gastroenterology or cosmetics.

Botulinum toxins are produced by the bacterium Clostridium botulinum. They have strong affinity for motor neurons and are able to cause flaccid muscle paralysis, as in the disease botulism, by blocking the release of the neurotransmitter acetylcholine, which is needed for muscle contraction.

However, in very small doses, botulinum toxins are used for cosmetic purposes and increasingly showing therapeutic potential in numerous medical disorders associated with muscular spasms: dystonias, strabismus, torticollis, gastrointestinal tract disorders, urological disorders, etc. The possibility of producing recombinant botulinum toxins would extend that therapeutic potential even further.

To test the potential of these toxins, researchers from I-Stem, IPSEN and the Neurodegenerative Diseases Laboratory teamed to develop a cellular model reflecting the physiological reality of the human body. Their work, published 5 December 2021 in Stem Cell Research & Therapy, furnishes an in vitro model of the human muscle-nerve system. The model comprises motor neurons derived from induced pluripotent stem cells in coculture with immortalized skeletal muscle cells. The team showed that junctions developed between the motor neurons* and the myotubes (a precursor cellular structure of muscle fibers) in their model, faithfully reflecting the in vivo neuromuscular junctions that transmit nerve impulses to muscle fibers to induce their contraction.

The model developed by the researchers is optogenetic, that is, the neuronal activity is controlled by light. Via calcium imaging, the team was able to directly visualize the impact of botulinum toxins on signal transmission.

The development of an in vitro model of muscle-nerve function able to predict and compare botulinum toxin efficacy is a major step forward for the study of the promising therapeutic potential of these proteins. The team’s achievement is yet another demonstration of the interest of pluripotent stem cells in the development of pertinent physiological cellular models and the study of therapeutic compounds.

References

Optogenetically controlled human functional motor endplate for testing botulinum neurotoxin

Stem Cell Research & Therapy (2021)

https://doi.org/10.1186/s13287-021-02665-3

  • * Motor neurons

    nerve cells specific to the stimulation of muscles and glands. Motor neurons comprise central and peripheral nerves all involved in commanding contractions.

Article posted on 27 January 2022

Share
Highlights

Latest news


Laboratoire de R&D - Abolis - campus Genopole

Abolis raises €35 million from an international consortium

Abolis has reached another milestone in its upscaling objectives. Convinced by the pertinence and robustness of its technology, an international consortium of industrials and funders will provide €35 million to the company.

Discover
Hélène Virasith, Program manager à Genopole, a accompagné trois startups génopolitaines Nutropy, AuraLIP et Onima au salon Futur Food Tech de Chicago - Juin 2024

Genopole at the Future FoodTech 2024 – Chicago

Genopole was in Chicago on June 17 and 18 for the Future Food Tech conference. Genopole® accompanied three of the biocluster's companies developing more sustainable food: Nutropy, AuraLIP and Onima. This was an opportunity for them to get noticed by major US groups and investors, and to gain an insight into North American market trends.

Discover
La délégation Genopole à BIO USA 2024

Genopole at BIO International 2024

The Genopole team at the BIO International Convention in San Diego pursued three main objectives: promote Genopole accompaniment to attract new talent, highlight biocluster companies and gather information on market and regulatory tendencies.

Discover
ACS Publication - Cover May 2024 - qui contient la publication du Lambe sur les nanopores

Lambe: A new milestone on the path to nanopore-based precision diagnostics

June 2024- Lambe has demonstrated the ability of an aerolysin nanopore to discriminate enantiomeric forms of peptide biomarkers useful for medical diagnostics.

Discover
Visite de la délégation

Genopole and the Netherlands: together to accelerate the development of alternative proteins

Genopole welcomed a Dutch delegation of close to 20 company representatives and alternative proteins researchers. The objective of the visit was to explore possibilities for research and business partnerships aimed at the development of new foods capable of meeting the future's nutritional, environmental, health, business and gustatory demands.

Discover
©Lionel Antoni - Plateforme d'irradiation expérimentale du LRGK - Plateforme génopolitaine mutualisée avec les acteurs de la communauté scientifique francilienne

The Experimental Irradiation Platform to serve the Île-de-France scientific community

Genopole is making available to the Île-de-France scientific community an Experimental Irradiation Platform equipped with a state of the art generator

Discover
Laina Freyer directrice scientifique, Felome

Felome Launches the Commercialization of Genetic Analyses for Companion Cats

Felome will begin the commercialization of a service offering genetic analyses for companion cats, to reveal their predispositions to over 50 diseases, identify their main physical traits, and their similarities with 14 types of breeds.

Discover
Lauréats de la promo 3 du programme Gene.iO - Genopole

Three Gene.iO whiz kids rewarded for their innovations

Three Gene.iO whiz kids, Alga Biologics, Fungu'it and Alt Biotech, rewarded for their innovations. Alga Biologics was among the 35 start-ups included in the French Blue Tech Index. Fungu'it and Alt Biotech, were selected to participate in 212 Founders, a start-up accompaniment and financing program by CDG Invest.

Discover
l'équipe iGEM 2023 Evry Paris-Saclay - Médaille d'or et p

A prize and gold for the 2023 Évry Paris-Saclay iGEM team

The international synthetic biology competition iGEM celebrated its 20th anniversary. From across the globe, the event drew more than 7,000 students in 400 teams from 66 countries. Genopole was there, among other actors in synthetic biology, to present the biocluster's advantages at its stand, and support the 17 students of the Évry Paris-Saclay team and their outstanding project, OptoGenEYEsis.

Discover
Genopole en mission exploratoire au Japon et en Corée du sud - octobre 2023

An exploratory mission to Japan and South Korea for Genopole

Genopole sent a team to Japan and South Korea to present itself and several of its accompanied businesses to major pharmaceutical corporations, investors and Asian bioclusters curious about biotechnological innovations and open to international partnerships.

Discover
Ibisc - Genopole's Laboratory

IBISC – Structure prediction for RNA complexes

passes a milestone in structure prediction for RNA complexes, key players in cell biology.

Discover
IBISC: A first predictive tool for the emerging field of bifunctional RNA

IBISC: A first predictive tool for the emerging field of bifunctional RNA

The IBISC laboratory has developed IRSOM2, an unprecedented bioinformatics tool for the prediction of bifunctional RNA, a relatively recently discovered class of RNA showing both an ability to code for proteins and an ability to perform biological roles.

Discover
Spectrométrie de masse à très haute spécificité - de la plateforme

Very-high-selectivity mass spectrometry

The mass spectrometry platform has acquired a Select Series Cyclic IMS system, an instrument with an unmatched ability to separate, characterize and quantify molecular species in complex samples.

Discover
Integrating informatics, structural biology and in vivo exploration for the discovery of new medicines

SABNP & Synsight: discovery of new medicines

SABNP and Synsight have validated an integrated, drug discovery approach uniting informatics, structural biology and in vivo exploration.

Discover
D4

D4Gen Hackathon: 48 hours and not a minute more to produce a digital tool for life sciences

The weekend event united more than 40 engineers, researchers and students, all specialists in and impassioned by the rapidly growing field of artificial intelligence.

Discover
Alexis Biton and Paul Carouen - Genopole - visiting the Research Triangle Park (USA) accompanied by 3 Genopole's companies

Genopole strengthens its ties with the Research Triangle Park

From Monday March 20 to Thursday March 24, Genopole's Partnership & Business Development team visited the Research Triangle Park biopark in North Carolina to strengthen scientific and industrial collaborations.

Discover
Visite du nouveau laboratoire d'Enalees lors de son inauguration

Enalees – a new proteomics laboratory

On Thursday, 6 April, Enalees inaugurated their new proteomics development and production laboratory for the veterinary market.

Discover
Lambe - Genopole's laboratory

Lambe: Detecting coagulation biomarkers with a natural nanopore

The Lambe laboratory showed proof of concept for a coagulation biomarker detection technology based on a natural nanopore.

Discover
Andrew Tolonen's team within the unit of Genomics Metabolics (Genoscope - CEA)

Genoscope: Biomanufacturing with bacteria

A team led by Andrew Tolonen has developed a method to optimize the genetic engineering of Clostridium genus bacteria for biotech applications

Discover
l’équipe « Dystrophies musculaires progressives » du laboratoire Généthon

Shining light on a key mechanism of Duchenne muscular dystrophy

A Genethon team has provided new insights on a complex genetic mechanism involved in mitochondrial dysfunction in Duchenne muscular dystrophy.

Discover
View all >
With the support from
Région île de France